1-2% of those receiving anthrax vaccine have had serious adverse events: Milvax and Vaccine Healthcare Centers

Although this conclusion is nothing new to many of us, it is gratifying to get confirmation from the National Academy of Engineering of the National Academy of Sciences, and to hear a Sandia National Labs scientist, Paul Kotula, acknowledge that 200 tries to reverse engineer the spores did not create an identical match. Which simply…

Yesterday, authors from the NIH, NY and Toronto published a paper describing their screening system for compounds against Ebola.  The method has identified a large number of approved substances with potential benefits. Many of them have been mentioned in this blog previously, such as clomifene, antimalarials and antiarrhythmics.  Ninety-five additional compounds were also found to…

Thanks to NGO Privacy International, we learn that over 300 companies can sell you your own surveillance package, incorporating 97 different technologies.  For example: Over the last four years, Privacy International has been gathering information from various sources that details how the sector sells its technologies, what the technologies are capable of and in some…

A new paper on anthrax vaccine safety, presumably published to support DHHS’ desire to test the vaccine in small children, has just been published online.  Its authors are all from CDC, and most have previously published papers of very poor quality supporting the so-called safety of anthrax vaccine.  I don’t understand why they still have…

Flu vaccine is being recommended for the entire US population over 6 months of age, starting this year. The (non-live) vaccines will contain 3 antigens, one of which is the antigen used for swine flu vaccines since late 2009. In 2009, DHHS Secretary Sibelius issued a Public Readiness and Emergency Preparedness Act waiver of liability…

See September 6 version above